Company Filing History:
Years Active: 2011-2021
Title: Khoi Ta: Innovator in Medical Device Technology
Introduction
Khoi Ta is a prominent inventor based in San Jose, California, known for his significant contributions to the field of medical devices. With a total of eight patents to his name, he has made remarkable advancements in technologies that enhance patient care and treatment options.
Latest Patents
Khoi Ta's latest patents include an embolus blood clot filter that is utilizable with a single delivery system or a single retrieval system through either femoral or jugular access. This innovative blood filter delivery system is designed to facilitate the delivery of a filter into a vein, utilizing an introducer and a push-rod with a spline member. The spline member is engineered to retain anchor members of the filter during the delivery process. In an alternative embodiment, the filter features diverging structures that can be independently collapsed into a cylindrical shape. Another notable patent is a stent that incorporates a bio-resorbable connector. This stent consists of multiple curved sections that form a helix and includes a connector made from bioresorbable material, which alters its spring constant upon exposure to biological material.
Career Highlights
Khoi Ta has established himself as a key figure in the medical device industry through his work at C. R. Bard, Inc. His innovative designs and patents have contributed to advancements in medical technology, particularly in the areas of vascular access and stent design.
Collaborations
Throughout his career, Khoi Ta has collaborated with notable professionals in the field, including John D. McDermott and Andrzej J. Chanduszko. These collaborations have further enhanced the development of his innovative medical devices.
Conclusion
Khoi Ta's contributions to medical technology through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to impact patient care and treatment methodologies significantly.